1. Horwich T, Kalantar-Zadeh K, MacLellan WR, Fonarow GC. Albumin Levels Predict Survival in Patients with Systolic Heart Failure. American Heart Journal. In press. 2. Afsarmanesh N, Horwich TB. Fonarow GC. Total cholesterol levels and mortality risk in nonischemic systolic heart failure. Am Heart J 2006; 152: 1077-83. 3. Eshaghian S, Horwich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 2006; 97: 1759-64. 4. Eshaghian S, Horwich TB, Fonarow GC. An Unexpected Inverse Relationship Between HbA1c Levels and Mortality in Patients with Diabetes and Advanced Systolic Heart Failure. Am Heart J 2006: 151: 91.e1 – 91.e6. 5. Horwich TB, Hamilton MA, Fonarow GC. B-type Natriuretic Peptide Levels in Obese Patients with Advanced Heart Failure. J Am Coll Cardiol 2006; 47: 85-90. 6. Ralli S, Horwich TB, Fonarow GC. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels, and mortality in advanced heart failure. Am Heart J 2005; 150: 1220-7. 7. Smooke S, Horwich TB, Fonarow GC. Insulin treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure. Am Heart J 2005;149:168-74. 8. Horwich T, Foster E, De Marco T, Tseng Z, Saxon L. Effects of Resynchronization Therapy on Cardiac Function in Pacemaker Patients 'Upgraded' to Biventricular Devices. J Cardiovasc Electrophysiol 2004; 15: 1284-9. 9. Tiersten A, Wo J, Jacobsen C, Weitzman A, Horwich T, Hesdorffer C, Savage D, and Troxel A. Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancer. Breast 2004; 13: 341-6. 10. Horwich TB, MacLellan WR, Fonarow GC. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol 2004;43:642-648. 11. Horwich TB, Lee SJ, Saxon LA. QRS prolongation predicts risk of inducible monomorphic ventricular tachycardia in patients referred for electrophysiologic studies. Am J Cardiol 2003: 92;804-9. 12. Horwich TB, Patel J, MacLellan WR, Fonarow GC. Cardiac Troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality in advanced heart failure. Circulation 2003;108:833-8. 13. Horwich TB, Hamilton MA, MacLellan WR, Fonarow GC. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 2002;8:216-224. 14. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is Associated with Worse Symptoms, Greater Impairment in Functional Capacity, and a Significant Increase in Mortality in Patients with Advanced Heart Failure. J Am Coll Cardiol 2002;39:1780-6. 15. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with advanced heart failure. J Am Coll Cardiol 2001; 38:789-95.